Origio EmbryoGen®/BlastGen™ (IVF Media for Embryo) - HSA Registration DE0507879
Access comprehensive regulatory information for Origio EmbryoGen®/BlastGen™ (IVF Media for Embryo) in the Singapore medical device market through Pure Global AI's free database. This CLASS D medical device is registered under HSA registration number DE0507879 and owned by ORIGIO A/S. The device was registered on March 10, 2023.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
EmbryoGen® is for the culture of human embryos until the 2-8 cell stage. EmbryoGen can also be used for embryo transfer on Day 2 or Day 3. BlastGen™ is for the culture of 4-8 cell stage human embryos to the blastocyst stage. BlastGen™ may also be used for embryo transfer.